Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human CNPase ELISA Kit (AC3521)
Cat.#: ASET-2110
Specifications
Description Human CNPase ELISA Kit allows for the in vitro quantitative determination of human CNPase concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1186 Human TRPC5 ELISA Kit (AC2597) Quantitative inquiry ASET-1153 Human Plexin A4 ELISA Kit (AC2564) Quantitative inquiry ASET-1483 Human Parvalbumin alpha ELISA Kit (AC2894) Quantitative inquiry ASET-1441 Human Dysbindin ELISA Kit (AC2852) Quantitative inquiry ASET-1377 Rat Adiponectin ELISA Kit (AC2788) Quantitative inquiry ASET-1173 Mouse Wnt8b ELISA Kit (AC2584) Quantitative inquiry ASET-2386 Human SCN11A ELISA Kit (AC3797) Quantitative inquiry ASET-2544 Human beta Arrestin 1 ELISA Kit (AC3955) Quantitative inquiry ASET-2449 Human TPH2 ELISA Kit (AC3860) Quantitative inquiry ASET-1573 Human GDNF ELISA Kit (AC2984) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket